Correlation Between DiaMedica Therapeutics and Imunon
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Imunon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Imunon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Imunon Inc, you can compare the effects of market volatilities on DiaMedica Therapeutics and Imunon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Imunon. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Imunon.
Diversification Opportunities for DiaMedica Therapeutics and Imunon
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between DiaMedica and Imunon is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Imunon Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imunon Inc and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Imunon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imunon Inc has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Imunon go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Imunon
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.76 times more return on investment than Imunon. However, DiaMedica Therapeutics is 1.31 times less risky than Imunon. It trades about 0.2 of its potential returns per unit of risk. Imunon Inc is currently generating about -0.1 per unit of risk. If you would invest 430.00 in DiaMedica Therapeutics on August 29, 2024 and sell it today you would earn a total of 78.00 from holding DiaMedica Therapeutics or generate 18.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
DiaMedica Therapeutics vs. Imunon Inc
Performance |
Timeline |
DiaMedica Therapeutics |
Imunon Inc |
DiaMedica Therapeutics and Imunon Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DiaMedica Therapeutics and Imunon
The main advantage of trading using opposite DiaMedica Therapeutics and Imunon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Imunon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imunon will offset losses from the drop in Imunon's long position.DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Imunon vs. Exicure | Imunon vs. Cyclacel Pharmaceuticals | Imunon vs. Histogen | Imunon vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |